Pharma Five is a registered firm based in India. We specialize in Named Patient Imports, Imported cancer drugs, Imported medicines in india.
Contact Us Pharma Five Door No. 74, Old No. 26, Fagun Mansion, 3rd Floor, Ethiraj Salai, Egmore, Chennai - 600008 +916374297988 info@pharmafive.org
Medicine name : Keytruda / Keytruda SC (with Padcev)
Generic name : Pembrolizumab + Enfortumab Vedotin
Manufactured By : Merck & Co. (MSD) / Astellas-Pfizer (Padcev)
Indications : Perioperative treatment of adults with resectable muscle-invasive bladder cancer (MIBC), regardless of cisplatin eligibility.
Medicine Description : A combination therapy for adults with resectable muscle-invasive bladder cancer (MIBC). Keytruda (Pembrolizumab) blocks PD-1 to enhance immune system activity, while Padcev (Enfortumab Vedotin) delivers targeted anticancer treatment to Nectin-4-expressing cancer cells. The combination is used as perioperative treatment before and after surgery.
Keytruda / Keytruda SC (with Padcev) (Pembrolizumab + Enfortumab Vedotin) is a combination cancer treatment used for adults with muscle-invasive bladder cancer. It combines pembrolizumab immunotherapy with enfortumab vedotin, an antibody-drug conjugate.
Pembrolizumab blocks the PD-1 pathway, helping the immune system recognise and attack cancer cells. Enfortumab vedotin targets Nectin-4 on cancer cells and delivers a cell-killing medicine into them.
This combination is prescribed for eligible adults with muscle-invasive bladder cancer who are candidates for bladder removal surgery. Treatment suitability is determined by an oncologist based on the patient’s condition and treatment plan.
The treatment is administered by healthcare professionals. Enfortumab vedotin is given as an intravenous infusion, while pembrolizumab is administered using the prescribed intravenous or approved subcutaneous formulation and schedule.
Common side effects may include skin rash, peripheral neuropathy, fatigue, itching, diarrhoea, hair loss, nausea, decreased appetite, weight loss and urinary tract infections.
Yes. Serious side effects may include severe skin reactions, high blood sugar, lung inflammation, nerve damage and immune-related complications affecting organs such as the liver, kidneys and intestines. Contact your healthcare provider promptly if you notice unusual or severe symptoms.
Treatment duration depends on the treatment phase, cisplatin eligibility, response and tolerability. It may be given before surgery and continued after surgery according to the oncologist’s prescribed schedule.
There is no specific universal alcohol restriction, but alcohol consumption should be discussed with the treating oncologist. Avoid alcohol if advised, particularly if liver-related problems or other treatment complications develop.
This combination may cause harm to an unborn baby. Pregnancy should be avoided during treatment and effective contraception should be used during treatment and for 4 months after the last pembrolizumab dose.
Yes. Always inform your oncologist about prescription medicines, over-the-counter products, vitamins and herbal supplements. Some medicines may affect treatment safety or increase the risk of side effects.
Contact your oncology treatment team as soon as possible for instructions if an appointment or dose is missed. Do not take an extra dose or change the treatment schedule yourself.
Food does not directly affect the administration of this treatment because it is given by infusion or injection rather than taken as an oral medicine. Follow your healthcare provider’s dietary advice.
Attend all scheduled appointments and blood tests. Report skin changes, numbness, tingling, breathing difficulties, severe diarrhoea, vision changes or symptoms of high blood sugar promptly. Do not stop or alter treatment without medical advice.
Store unopened Keytruda and Padcev vials in a refrigerator at 2°C to 8°C in their original cartons to protect them from light. Do not freeze or shake the vials. Follow the product-specific instructions for prepared solutions.
Pharma Five may assist with information and import facilitation for personal medical use, subject to applicable regulations and required documentation. A valid prescription and supporting documents may be required. Pharma Five assists in its procurement.